Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1981 1
1984 3
1985 3
1987 1
1988 1
1989 2
1990 1
1992 4
1994 1
1995 1
1997 1
2000 1
2001 1
2003 4
2006 1
2007 1
2008 2
2009 8
2010 9
2011 4
2012 9
2013 8
2014 12
2015 10
2016 11
2017 10
2018 16
2019 17
2020 22
2021 32
2022 31
2023 18
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Results by year

Filters applied: . Clear all
Page 1
MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.
García-Criado Á, Rimola J, Seijo S, Darnell A, Belmonte E, Sapena V, Moreno-Rojas J, Pérez V, Hernández-Gea V, Ayuso C, Reig M, García-Pagán JC, Bruix J. García-Criado Á, et al. Among authors: reig m. Liver Cancer. 2023 Aug 18;13(2):203-214. doi: 10.1159/000533598. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751551 Free PMC article.
Evidence and Choice: The BCLC Vision for Tailoring Clinical Decision-Making.
Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. Reig M, et al. J Hepatol. 2024 May 8:S0168-8278(24)00321-0. doi: 10.1016/j.jhep.2024.04.023. Online ahead of print. J Hepatol. 2024. PMID: 38729354 No abstract available.
[Barriers and facilitators of colorectal cancer screening access].
Schenfeld Y, Schernenco J, Bellando MB, Robles M, Picardi G, Dopazo Danieli IM, Albanesi L, Reig ME, Esandi ME, Bruzzone A. Schenfeld Y, et al. Among authors: reig me. Medicina (B Aires). 2024;84(2):267-278. Medicina (B Aires). 2024. PMID: 38683512 Free article. Spanish.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Among authors: reig m. Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19. Ann Oncol. 2024. PMID: 38382875 Free article. Clinical Trial.
Systemic therapies in hepatocellular carcinoma: A revolution?
Fortuny M, Sanduzzi-Zamparelli M, Reig M. Fortuny M, et al. Among authors: reig m. United European Gastroenterol J. 2024 Mar;12(2):252-260. doi: 10.1002/ueg2.12510. Epub 2024 Jan 24. United European Gastroenterol J. 2024. PMID: 38267015 Free PMC article. Review.
Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus.
Yanagihara TK, Tepper JE, Moon AM, Barry A, Molla M, Seong J, Torres F, Apisarnthanarax S, Buckstein M, Cardenes H, Chang DT, Feng M, Guha C, Hallemeier CL, Hawkins MA, Hoyer M, Iwata H, Jabbour SK, Kachnic L, Kharofa J, Kim TH, Kirichenko A, Koay EJ, Makishima H, Mases J, Meyer JJ, Munoz-Schuffenegger P, Owen D, Park HC, Saez J, Sanford NN, Scorsetti M, Smith GL, Wo JY, Yoon SM, Lawrence TS, Reig M, Dawson LA. Yanagihara TK, et al. Among authors: reig m. Pract Radiat Oncol. 2024 Mar-Apr;14(2):134-145. doi: 10.1016/j.prro.2023.08.016. Epub 2024 Jan 19. Pract Radiat Oncol. 2024. PMID: 38244026
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide.
Ortiz-Rivero S, Peleteiro-Vigil A, Abete L, Lozano E, Hammer HS, Giacomo SD, Abad M, Boix L, Forner A, Reig M, Macias RIR, Pötz O, Marin JJG, Briz O. Ortiz-Rivero S, et al. Among authors: reig m. Biomed Pharmacother. 2024 Jan;170:116038. doi: 10.1016/j.biopha.2023.116038. Epub 2023 Dec 22. Biomed Pharmacother. 2024. PMID: 38141281 Free article.
231 results